𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of E-cadherin transcriptional regulators in ovarian carcinoma

✍ Scribed by Sivan Elloul; Ilvars Silins; Claes G. Tropé; Avi Benshushan; Ben Davidson; Reuven Reich

Book ID
106117638
Publisher
Springer
Year
2006
Tongue
English
Weight
367 KB
Volume
449
Category
Article
ISSN
1432-2307

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

E-cadherin expression in upper-urinary-t
E-cadherin expression in upper-urinary-tract carcinoma
✍ Kuniaki Nakanishi; Toshiaki Kawai; Chikao Torikata; Takashi Aurues; Tomosumi Ike 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 181 KB 👁 1 views

Carcinoma of the upper urinary tract is a relatively rare neoplasm, and few studies have dealt with clinicopathological findings and prognosis in a large number of cases. The purpose of our investigation was to look for a possible relation between E-cadherin (E-CD) immunoreactivity and clinicopathol

E-cadherin and α-, β-, and γ-catenin pro
E-cadherin and α-, β-, and γ-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions
✍ Ben Davidson; Aasmund Berner; Jahn M. Nesland; Bjørn Risberg; Heidi S. Berner; C 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB 👁 1 views

The aims of this study were ®rstly, to investigate the expression of E-cadherin complex proteins in ovarian carcinoma cells in serous effusions and in primary and metastatic lesions; and secondly to study the value of these four proteins and calretinin, a mesothelial marker, in the differential diag

Prognostic value of E-cadherin expressio
Prognostic value of E-cadherin expression in 413 gastric carcinomas
✍ Helmut E. Gabbert; Wolfram Mueller; Anke Schneiders; Stephanie Meier; Roland Mol 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 718 KB

E-cadherin is a Ca2+-dependent intercellular adhesion molecule known to exert an invasion-suppressor function. In the present study, E-cadherin expression was imrnunohistochemically investigated in a retrospective series of 4 I 3 RO-resected gastric carcinomas using the monoclonal antibody (MAb) 5H9